Published in

Nature Research, Nature Genetics, 2(47), p. 164-171, 2015

DOI: 10.1038/ng.3185



Export citation

Search in Google Scholar

Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

Journal article published in 2015 by Andreas du Bois, Anne M. van Altena, Elizabeth J. van Rensburg, Miguel de la Hoya, Jamal Zidan, Wei Zheng, Argyrios Ziogas ORCID, E. J. Van Rensburg, Jeffrey N. Weitzel ORCID, Alessandra Viel ORCID, Xianshu Wang, Joseph Vijai ORCID, Christine Walsh, Els Van Nieuwenhuysen, Ignace Vergote and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO


Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and BRCA2 mutation carriers who are at high risk of EOC. After imputation to 1000 Genomes Project data, we assessed associations of 11 million genetic variants with EOC risk from 15,437 cases unselected for family history and 30,845 controls and from 15,252 BRCA1 mutation carriers and 8,211 BRCA2 mutation carriers (3,096 with ovarian cancer), and we combined the results in a meta-analysis. This new study design yielded increased statistical power, leading to the discovery of six new EOC susceptibility loci. Variants at 1p36 (nearest gene, WNT4), 4q26 (SYNPO2), 9q34.2 (ABO) and 17q11.2 (ATAD5) were associated with EOC risk, and at 1p34.3 (RSPO1) and 6p22.1 (GPX6) variants were specifically associated with the serous EOC subtype, all with P < 5 × 10(-8). Incorporating these variants into risk assessment tools will improve clinical risk predictions for BRCA1 and BRCA2 mutation carriers.